This is ALL THINGS CONSIDERED from NPR News. I'm Melissa Block. In Britain, the radical cleric Abu Hamza has lost his final battle to avoid extradition to the United States. Britain's high court judges ruled today that Hamza and four other suspected terrorists must now be sent to the U.S. to face trial on terror charges related to al-Qaida. That ends a legal battle that, in Hamza's case, has lasted nearly 14 years. Vicki Barker reports from London.
Multi-platinum musician, producer, activist and aspiring politician Wyclef Jean's new memoir Purpose: An Immigrant's Story provides a candid insight into his life and career. In an interview airing on Monday's Tell Me More, he sits down with host Michel Martin to discuss his family, his music and his hopes for Haiti. Jean also talks about his rocky romantic past with Lauryn Hill, how it inspired his music, and how it eventually broke up the group that made them both stars, The Fugees.
I'm Michel Martin and this is TELL ME MORE from NPR News. Coming up, we will hear from musician, activist and now author Wyclef Jean. He's out with a new memoir and we'll hear from him about his career and very interesting life story, and yes, he answers questions that people have about relationships in his life. That's coming up later in the program.
For the past decade, al-Qaida has been a top-down organization.
Letters seized at Osama bin Laden's compound in Pakistan showed that he was a hands-on manager, approving everything from operations to leadership changes in affiliate groups.
But there's early intelligence that al-Qaida may have had a small role in the attack on the U.S. Consulate in Benghazi, Libya, which killed four Americans, including Ambassador Chris Stevens, on Sept. 11.
If al-Qaida involvement is confirmed, it may signal that al-Qaida has changed.
Originally published on Fri October 5, 2012 4:24 pm
The news that the cost of personal genome sequencing will soon drop as low as $1,000 has generated a quite a bit of interest and concern — from medical researchers, biotech companies, bioethicists and the average consumer alike.
NPR's Rob Stein explored many of the implications of this technology in his four-part series "The $1,000 Genome." They're complicated, to say the least.